Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Amneal Pharmaceuticals LLC currently has 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. These 2 actions are distributed among 2 distinct examiners. Despite having multiple examiners involved, the entire pending workload is housed within a distinct art unit. This indicates that the company's current patent applications are technically similar enough to be grouped together by the patent office.
BAUER, BRIANNA LEE is listed as the busiest examiner for the portfolio, holding 1 pending action. Since the total number of pending office actions is 2 and there are 2 distinct examiners, each examiner is responsible for one action. The focus on a single distinct art unit for the 2 pending office actions suggests a streamlined technical scope for the company's current filings in the Medical Devices & Mechanical Engineering sector. Practitioners will need to interface with 2 distinct examiners, including BAUER, BRIANNA LEE, to address the 2 pending office actions currently active for the company.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BAUER, BRIANNA LEE | 1 | 100.0% | +0.0% |
| SHAH, NILAY J | 1 | 76.3% | +46.9% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18717086 | COMPOUNDS FOR THE TREATMENT OF CANCER | BAUER, BRIANNA LEE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18240029 | REFILL KIT FOR IMPLANTABLE PUMP | SHAH, NILAY J | 16d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18240029 | REFILL KIT FOR IMPLANTABLE PUMP | SHAH, NILAY J | 16d |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18717086 | COMPOUNDS FOR THE TREATMENT OF CANCER | BAUER, BRIANNA LEE | — | §103DP | Non-Final OA | — | Pending | Jun 06, 2024 |
| 18240029 | REFILL KIT FOR IMPLANTABLE PUMP | SHAH, NILAY J | 3783 | §103§112 | Non-Final OA | 16d | Pending | Aug 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial